| |
| |
|
| Insider
Information: |
Iwicki Mark T |
| Relationship: |
Director |
| City: |
Marlborough |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
795,522 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,069,442 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
795,522 |
|
|
| Total
Value |
$7,069,442 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2015-08-11 |
0 |
Premium* |
|
|
Pulmatrix Inc |
PULM |
Director |
2018-04-03 |
307,000 |
2018-04-03 |
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
|
2024-01-04 |
286,315 |
2020-10-26 |
0 |
Premium* |
|
|
Third Harmonic Bio, Inc. |
THRD |
Director |
2022-09-14 |
128,631 |
|
0 |
Premium* |
|
|
Merus Nv |
MRUS |
Director |
2023-04-14 |
73,576 |
2023-04-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-04 |
4 |
AS |
$6.73 |
$30,547 |
D/D |
(4,539) |
286,315 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,300 |
290,854 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
158,873 |
276,554 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
71,715 |
117,681 |
0 |
- |
|
| MRUS |
Merus Nv |
Director |
– • – |
2023-04-14 |
4 |
OE |
$6.57 |
$534,679 |
D/D |
73,576 |
73,576 |
0 |
- |
|
| THRD |
Third Harmonic Bio, Inc. |
Director |
– • – |
2022-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
128,631 |
|
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-06-27 |
4 |
AS |
$0.37 |
$2,951 |
D/D |
(7,975) |
251,183 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-01-04 |
4 |
AS |
$1.30 |
$12,373 |
D/D |
(9,518) |
259,158 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2021-10-26 |
4 |
AS |
$1.80 |
$49,676 |
D/D |
(27,598) |
268,676 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF EXECUTIVE OFFICER |
• • – |
2021-06-28 |
4 |
AS |
$5.77 |
$43,771 |
D/D |
(7,586) |
296,274 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Chief Executive Officer |
• • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
76,000 |
303,860 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Chief Executive Officer |
• • – |
2020-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
178,300 |
227,860 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$1,365,062 |
D/D |
(39,567) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,840 |
47,407 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
39,567 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
33,125 |
0 |
- |
|
| PULM |
Pulmatrix Inc |
Director |
– • – |
2018-04-03 |
4 |
B |
$0.00 |
$0 |
D/D |
307,000 |
307,000 |
2.31 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2018-02-26 |
4 |
B |
$32.00 |
$300,000 |
D/D |
9,375 |
29,375 |
2.39 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2015-08-11 |
4 |
B |
$16.00 |
$320,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
